N-[4-[2-(Propylamino)Ethyl]Phenyl]-4-(Trifluoromethoxy)Benzenesulfonamide Hydrochloride N-[4-[2-(丙基氨基)乙基)苯基] -4-(三氟甲氧基)-苯磺酰胺盐酸盐
CAS 1783978-03-9 MFCD883978039
化学结构图
SMILES:
别名和识别编码
| Chemical Name | N-[4-[2-(Propylamino)Ethyl]Phenyl]-4-(Trifluoromethoxy)Benzenesulfonamide Hydrochloride |
|---|---|
| Chemical Name Translation | N-[4-[2-(丙基氨基)乙基)苯基] -4-(三氟甲氧基)-苯磺酰胺盐酸盐 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Vonderfecht SL, et al. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence. Toxicol Pathol. 2004 May-Jun;32(3):318-25.
- [1]. Rudmann DG, et al. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864. Toxicol Pathol. 2004 May-Jun;32(3):326-32.
- [1]. Rudmann DG, et al. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864. Toxicol Pathol. 2004 May-Jun;32(3):326-32.
- [2]. Vonderfecht SL, et al. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence. Toxicol Pathol. 2004 May-Jun;32(3):318-25.
